Analysis of long-term serological and histological changes after eradication of .

Stratification of gastric cancer risk by measuring serological biomarkers is useful for screening of gastric cancer. However, this method has problem such as overlooking past infected patients. We aimed to evaluate the association between infection status and serological biomarkers. We divided 5,268 patients according to infection status and past infected patients were divided into 12 groups according to time elapsed since eradication. We analyzed mean serum immunoglobulin G antibody, pepsinogen titers, histological and endoscopic atrophy score of each group. Mean immunoglobulin G antibody showed a decreasing tendency, there was no significant difference from the uninfected group at 11 years after eradication ( = 0.19). PGI, PGII decreased in short term after eradication. However, both PGI and PGII gradually increased as long-term changes after eradication, became comparable to those in the uninfected group ( = 0.41,  = 0.37, respectively). Histological atrophy improved gradually, became equivalent to uninfected group. Endoscopic atrophy score did not improve for long term after eradication. In conclusion, patients with long term after eradication reach the uninfected condition serologically, histologically. Endoscopic assessment of gastric mucosal atrophy may be useful for accurate assessment of gastric cancer risk.